GlaxoSmithKline PLC ( GSK ) will begin trading ex-dividend on August 07, 2013. A cash dividend payment of $0.5532 per share is scheduled to be paid on October 03, 2013. Shareholders who purchased GSK stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 0.55% increase over the prior quarter. At the current stock price of $52.1, the dividend yield is 4.25%.
The previous trading day's last sale of GSK was $52.1, representing a -3.52% decrease from the 52 week high of $54 and a 25% increase over the 52 week low of $41.68.
GSK is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). GSK's current earnings per share, an indicator of a company's profitability, is $2.56. Zacks Investment Research reports GSK's forecasted earnings growth in 2013 as -.48%, compared to an industry average of -3.8%.
For more information on the declaration, record and payment dates, visit the GSK Dividend History page.
Interested in gaining exposure to GSK through an Exchange Traded Fund [ETF]?
The following ETF(s) have GSK as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS ( PPH )
- FlexShares International Quality Dividend Defensive Index Fund ( IQDE )
- FlexShares International Quality Dividend Index Fund ( IQDF )
- FlexShares Morningstar Developed Markets ex-US Factor Tilt Ind ( TLTD ).
The top-performing ETF of this group is PPH with an increase of 9.64% over the last 100 days. It also has the highest percent weighting of GSK at 5.47%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.